Jim Olson, MD, PhD, Sarah Hughes Chair for Pediatric Oncology, Member, Fred Hutchinson Cancer Research Center, Attending Physician, Seattle Children’s Hospital & Professor of Pediatrics, University of Washington, “From Scorpions to Sunflowers: Tapping into Nature for Cancer, Arthritis, and Other Drugs”
As a physician-scientist, Dr. Olson cares for children with brain tumors and conducts research that focuses on discovering and developing new cancer therapies. His lab’s work has led to more than a dozen national clinical trials, of which he leads a Phase III trial through the Children’s Oncology Group.
Dr. Olson is the founder of Presage Biosciences and Blaze Bioscience. His lab invented the chlorotoxin-based Tumor Paint, which led to the development by Blaze of the clinical candidate Tozuleristide (BLZ‑100), now in human trials. He authored “Clinical Pharmacology Made Ridiculously Simple,” which has been the most used pharmacology board review book for more than 25 years.
Dr. Olson earned his Ph.D. in Pharmacology in 1989 and his M.D. in 1991, both from the University of Michigan. He then completed his residency in pediatrics in 1994 and his fellowship in pediatric oncology in 1997, both at the University of Washington. Dr. Olson is currently a Full Member at the Fred Hutchinson Cancer Research Center, a Professor at the University of Washington, and an Attending Physician at Seattle Children’s Hospital.